« Tracking your data: Maria Gardner and Alyson Youngblood on the risks of “Internet of Bodies” devices | Main | Class critics: Lisa R. Pruitt on the film Hillbilly Elegy and popular representations of the white working class »



Feed You can follow this conversation by subscribing to the comment feed for this post.

Tyra Elliot

The main objective of Garijo's article "Full Measure of Humanity" Is to show that certain indiviuals are underrepresented when it comes to clinical trials such as females, Blacks, Latinx. Meanwhile Asians and males are over represented when it comes to clinical trials. I really like how Garijo counters naysayers perspective about the dangers of not representing each group accurately. Garijo says "To do otherwise will risk not just the creation of insufficient or potentially ineffective treatments, but will also foster additional skepticism toward medical science from those who are inclined to doubt such expertise." I feel this signaled to the reader "who cares" and "so what" statements. I think Garijo places these statements to put detail on how people being unrepresented effects all of us. In regards to the video "Invisible Women" by Caroline Criado Perez explains why women are more likely to be severely injured in a car crash then men. Primarily because they never test the cars to see if they are suitable for women drivers, which is incredibly surprising to hear . I personally just assumed that female test dummies existed, but sadly they don't. The research from both of the articles compare the disparities in clinical trials and data and why it is so important. They both bring evidence on the differences between the underrepresented group and the overrepresented group.

alexis morales

I believe that it is essential for there to be more of a diversity included in clinical trials. In most clinical trials, there is not a large percentage of minorities. This can cause major issues. It is understandable when people are hesitant to participate in these trials because it is fear of the unknown. Although this may be the case this leaves a bigger fear of the unknown: figuring out if the treatment is suitable for everyone. Data studied in these trials are not completely reliable to all because we are not all the same. When it comes down to “who cares” or “what does it matter”, it does because we are all human. We should all be able to have the same access to medical treatment but unfortunately, we are not. This is becoming a global issue that is not only limited to certain illnesses. We lack studies of a variety that will be able to work for everyone. We must be able to find ways to help those who feel as if they will not be. I believe that people who struggle also become hesitant because they are unsure it is an affordable treatment that will be produced one day. To be able to make these changes we all must come together to find a solution and continue to invest in the future of helping everyone safely.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been posted. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Your Information

(Name and email address are required. Email address will not be displayed with the comment.)

About They Say / I Blog

  • New readings posted monthly, on the same issues that are covered in “They Say / I Say” with Readings—and with a space where readers can comment, and join the conversation.

Follow us on Twitter to get updates about new posts and more! @NortonWrite

Become a Fan